These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 27492049)

  • 1. Breaking Down the Barriers to Precision Cancer Nanomedicine.
    von Roemeling C; Jiang W; Chan CK; Weissman IL; Kim BYS
    Trends Biotechnol; 2017 Feb; 35(2):159-171. PubMed ID: 27492049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic Potential of Nanomedicine in Prostate Cancer Immunotherapy: Breakthroughs and Prospects.
    Jiang Y; Wang C; Zu C; Rong X; Yu Q; Jiang J
    Int J Nanomedicine; 2024; 19():9459-9486. PubMed ID: 39371481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unmet needs in developing nanoparticles for precision medicine.
    Schwartz S
    Nanomedicine (Lond); 2017 Feb; 12(4):271-274. PubMed ID: 28093937
    [No Abstract]   [Full Text] [Related]  

  • 4. Nanomedicines Targeting the Tumor Microenvironment.
    Tong R; Langer R
    Cancer J; 2015; 21(4):314-21. PubMed ID: 26222084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-associated macrophages, nanomedicine and imaging: the axis of success in the future of cancer immunotherapy.
    Zanganeh S; Spitler R; Hutter G; Ho JQ; Pauliah M; Mahmoudi M
    Immunotherapy; 2017 Sep; 9(10):819-835. PubMed ID: 28877626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanoparticle-based strategies for cancer immunotherapy and immunodiagnostics.
    Grimaldi AM; Incoronato M; Salvatore M; Soricelli A
    Nanomedicine (Lond); 2017 Oct; 12(19):2349-2365. PubMed ID: 28868980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanomedicine approaches to improve cancer immunotherapy.
    Qiu H; Min Y; Rodgers Z; Zhang L; Wang AZ
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2017 Sep; 9(5):. PubMed ID: 28296286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer nanoimmunotherapy using advanced pharmaceutical nanotechnology.
    Li W; Wei H; Li H; Gao J; Feng SS; Guo Y
    Nanomedicine (Lond); 2014 Nov; 9(16):2587-605. PubMed ID: 25490427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Personalized Nanoparticles for Cancer Therapy: A Call for Greater Precision.
    Sahakyan N; Haddad A; Richardson S; Forcha-Etieundem V; Christopher L; Alharbi H; Campbell R
    Anticancer Agents Med Chem; 2017; 17(8):1033-1039. PubMed ID: 28042778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of individualized anti-metastasis strategies by engineering nanomedicines.
    He Q; Guo S; Qian Z; Chen X
    Chem Soc Rev; 2015 Oct; 44(17):6258-6286. PubMed ID: 26056688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunomodulatory Nanomedicine.
    Bartneck M
    Macromol Biosci; 2017 Oct; 17(10):. PubMed ID: 28383783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting tumor associated macrophages: The new challenge for nanomedicine.
    Andón FT; Digifico E; Maeda A; Erreni M; Mantovani A; Alonso MJ; Allavena P
    Semin Immunol; 2017 Dec; 34():103-113. PubMed ID: 28941641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of engineered nanoparticles on the innate immune system.
    Liu Y; Hardie J; Zhang X; Rotello VM
    Semin Immunol; 2017 Dec; 34():25-32. PubMed ID: 28985993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New Strategies in the Design of Nanomedicines to Oppose Uptake by the Mononuclear Phagocyte System and Enhance Cancer Therapeutic Efficacy.
    Zhou Y; Dai Z
    Chem Asian J; 2018 Nov; 13(22):3333-3340. PubMed ID: 29441706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of integrated cancer nanomedicine in overcoming drug resistance.
    Iyer AK; Singh A; Ganta S; Amiji MM
    Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1784-802. PubMed ID: 23880506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanoparticulate immunotherapy for cancer.
    Kapadia CH; Perry JL; Tian S; Luft JC; DeSimone JM
    J Control Release; 2015 Dec; 219():167-180. PubMed ID: 26432555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emerging concepts in designing next-generation multifunctional nanomedicine for cancer treatment.
    Chakraborty K; Tripathi A; Mishra S; Mallick AM; Roy RS
    Biosci Rep; 2022 Jul; 42(7):. PubMed ID: 35638450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smart nanoparticles improve therapy for drug-resistant tumors by overcoming pathophysiological barriers.
    Liu JP; Wang TT; Wang DG; Dong AJ; Li YP; Yu HJ
    Acta Pharmacol Sin; 2017 Jan; 38(1):1-8. PubMed ID: 27569390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dendrimers for cancer immunotherapy: Avidity-based drug delivery vehicles for effective anti-tumor immune response.
    Rawding PA; Bu J; Wang J; Kim DW; Drelich AJ; Kim Y; Hong S
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2022 Mar; 14(2):e1752. PubMed ID: 34414690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancing Cancer Immunotherapy Treatment Goals by Using Nanoparticle Delivery System.
    Muluh TA; Chen Z; Li Y; Xiong K; Jin J; Fu S; Wu J
    Int J Nanomedicine; 2021; 16():2389-2404. PubMed ID: 33790556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.